Male hormone replacement therapy (MHRT) with low-dose testosterone was both safe and effective, according to a presentation on June 21 at Endo 2002, the 84th annual meeting of The Endocrine Society.
“Decrease in testosterone with age parallels unfavorable changes in organs upon which androgens act,” write F. M. Ellyin and colleagues at The Chicago Medical School in Illinois. “The goal of MHRT is to prevent, stabilize or reverse these detrimental target-organ changes.”
The authors studied beneficial effects and safety of low-dose testosterone therapy in healthy men aged 65 to 85 years. Compared with healthy middle-aged males, baseline FT was borderline low, but LH, FSH, PRL, and E2 were normal. Since 1993, the subjects received intramuscular testosterone cypionate or testosterone enanthate, 25 mg weekly or 50 mg every 2 weeks.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!